baber/WOPTO huggingface dataset:
Patent CA-2487930-A1 (CA)
Inventor: MASCHOTTA PETER
IPC: A61B5/117
Filed: 2003-10-08
Abstract: 1. Touchless biometric recognition 2.1 The invention is underlied by the problem to specify a method of the type initially mentioned, with which an improved touchless biometric recognition is possible cheaply. 2.2 According to the invention, the problem is solved by mutually carrying out the observing, checking and/or correcting using the imaging facilities respectively and thereby acquiring position, attitude and degree of rotation. 2.3 The invention relates to a method for touchless recognition of biometric attributes of a body part, in particular of finger lines, comprising optical imaging from different points of view by several imaging facilities, observing and/or checking the position and/or the attitude of the body part to be recognized and/or correcting the images of the imaging facilities regarding the position and/or the attitude, wherein the shape of the body part is used.
Patent CA-2490925-A1 (CA)
Title: Sloped table top and a table having a sloped table top
Inventor: RIACH JEFFREY M
IPC: A47B13/08
Filed: 2004-12-23
Abstract: A table top including a table surface member having a lateral planar section, and a sloped section at one end of the table surface member. The sloped section is angled upwardly toward an end edge relative to the lateral planar section of the table surface member. In one embodiment, the table top includes a first layer cushion having a wedge portion supported on the sloped section of the table surface member. The table top may be provided with support members that extend downwardly from the periphery of the table top, but not from the end edge. The support members of one embodiment include curved portions proximate to the sloped section.
Patent CA-2492392-A1 (CA)
Inventor: COWIE ROSS LYELL
IPC: H01L31/062
Filed: 2005-01-14
Abstract: Aide à la mobilité, par exemple une marchette, un fauteuil roulant, un fauteuil de transport, un siège de douche ou un ambulateur, pour offrir un support aux personnes blessées ou souffrantes dans leurs activités ou leurs déplacements. L'aide comporte une plate-forme d'assise solide en deux parties ainsi qu'une structure pour la répartition du poids de l'utilisateur sur l'armature. De plus, les deux parties de la plate-forme d'assise sont liées par une charnière permettant à l'appareil de se plier pour le rangement. Un mécanisme de verrouillage maintient la structure en place et une poignée facilite le pliage de l'appareil pour le rangement.
Patent CA-2492411-A1 (CA)
Title: Golf putter head with a visual alignment aid and an increased moment of inertia
Inventor: HAINES DEREK W
IPC: A63B53/04
Filed: 2005-01-13
Abstract: A golf putter head includes a face member with a front surface arranged for impacting a golf ball. A first arm extends substantially rearwardly from a heel end of the face member, a second arm extends substantially rearwardly from a toe end of the face member, and a central member extends rearwardly from the face member intermediate the heel and toe ends thereof. The central member is connected to the first and second arms rearwardly of the face member. A first cavity is formed in an upper surface of the central member between the first and second openings, and a second cavity is formed in the upper surface of the central member rearwardly of the first cavity and rearwardly of the first and second openings. First and second inserts are disposed, respectively, in the first and second cavities. The first cavity and the first insert each have a generally elongated crescent shape with a concave end while the second cavity and the second insert each have a generally semicircular shape with a convex side. In order to provide a visual alignment aid, the convex sides of the second cavity and the second insert are aligned with and complement the concave ends of the first cavity and the first insert. The first and second inserts have a color which contrasts with the face member, the first and second arms, and the central member to enhance the visual alignment aid.
Patent CA-2496703-A1 (CA)
Inventor: TSUTSUMI SADAMI
IPC: A61C19/00
Filed: 2003-08-25
Abstract: Dentition three-dimensional data and jaw-bone three-dimensional data are collected from a patient and they are combined. According to the combined data, dental crown data for making up for data on a lost tooth and occlusion data on a dental crown represented by the dental crown data are created. Whe n an occlusion force according to the occlusion data is exerted on the occlusi on face of a dental crown, a mechanical evaluation factor is produced in a jaw bone. The mechanical evaluation factor produced near the place where an artificial tooth root supporting a dental crown is to be implanted is calculated. The implantation place is determined so that the mechanical evaluation factor may be smaller and the mechanical load on the jaw bone fro m the opposed tooth during mastication may be lighter.
Patent CA-2497731-A1 (CA)
Title: Magnetorheological polishing devices and methods
Inventor: GORODKIN SERGEI R
IPC: B24B51/00
Filed: 1994-06-03
Abstract: A method of polishing an object is disclosed. In one embodiment, as shown in the figure, the method comprises the steps of creating a polishing zone (10) within a magnetorheological fluid (2); determining the characteristics of the contact between the object and the polishing zone necessary to polish the object (4); controlling the consistency of the fluid (2) in the polishing zone (10); bringing the object (4) into contact with the polishing zone (10) of the fluid (2); and moving at least one of said object (4) and said fluid (2) with respect to the other. Also disclosed is a polishing device (1). In one embodiment, the device comprises a magnetorheological fluid (2), a means (6) for inducing a magnetic field, and a means for displacing the object (4) to be polished or the means (6) for inducing a magnetic field relative to one another.
Patent CA-2499465-A1 (CA)
Title: Biologically active compounds
Inventor: QUIBELL MARTIN
IPC: A61P19/00
Filed: 2003-07-15
Abstract: Compounds of general formula (I) wherein: Z = CR3R4, where R3 and R4 are independently chosen from CO-7-alkyl P1 = CR5R6, P2 = O, CR7R8 or NR9, Y = CR10R11-C(O) or CR10R11-C(S) or CR10R11-S(O) or CR10R11-SO2(X)o=.CR16R17 (W) n = 0, S, C(O), S(O) or S(O)2-or NR18 (V)m = C(O), C(S), S(O), S(O)2, S(O)2NH, OC(O), NHC(O), NHS(O), NHS(O)2, OC(O)NH, C(O)NH or CR19R20, C=N-C(O)-OR19 or C=N-C(O)-NHR19, U = a stable. 5- to 7-membered monocyclic or a stable 8- to 11- membered bicyclic ring which is either saturated or unsaturated, and which includes zero to four heteroatoms and their salts, hydrates, solvates, complexes and prodrugs are inhibitors of cathepsin K and other cysteine protease inhibitors and are useful as therapeutic agents, .for example in osteoporosis, Paget's disease gingival diseases such as gingivitis and periodontitis, hypercalaemia of malignancy, metabolic bone disease, diseases involving matrix or cartilage degradation, in particular osteoarthritis and rheumatoid arthritis and neoplastic diseases. The compounds are also useful for validating therapeutic target compounds.
Patent CA-2501277-A1 (CA)
Title: Battery separator with antistatic properties
Inventor: NGUYEN KHUY V
IPC: H01M50/457
Filed: 2005-03-17
Abstract: A battery separator comprising: a microporous polyolefin film having from 0.1% to 50% by weight of a block copolymer including a polyetheresteramide monomer.      In this battery separator the polyolefin is selected from the group consisting of: polyethylene, polypropylene, polybutylene, polymethylpentene, mixtures thereof, and copolymers thereof. Preferably the polyolefin is polyethylene, mixtures of polyethylene and copolymers of polyethylene, or polypropylene, mixtures of polypropylene and copolymers of polypropylene and has less than or equal to 5% by weight of the block copolymer. In the battery separator of the invention, the microporous film generally has a thickness of no greater than 200 microns, a porosity in the range of 10 to 90%, and a pore size in the range of 0.005 micron to 1.5 micron.
Patent CA-2501756-A1 (CA)
Inventor: QUICK MICHELLE K
IPC: C12Q1/48
Filed: 2003-10-10
Abstract: Isolated phosphorylated troponin I proteins useful in diagnosing and monitoring the phosphorylation state of injured muscle tissue are provided. Also provided are compounds, kits and methods for assessing the phosphorylation state of these troponin I proteins and modulating the phosphorylation state of these troponin I proteins in a subject.
Patent CA-2501770-A1 (CA)
Inventor: PATEL AMIT R
IPC: H01H3/00
Filed: 2003-10-09
Abstract: L'invention concerne un agencement que l'on peut assembler avec une enceinte d'équipement électrique installé existante ayant une porte d'accès ou pendant la fabrication et l'assemblage de ladite enceinte d'équipement électrique augmentant les capacités de résistance aux arcs et les caractéristiques de l'enceinte d'équipement électrique. La résistance aux arcs de l'enceinte d'équipement électrique est augmentée via l'apport d'installations de protection disposées à proximité de l'ouverture d'accès de l'enceinte afin d'empêcher sensiblement que la chaleur générée par la formation d'arcs au sein de l'enceinte n'atteigne la porte d'accès de l'enceinte.
Patent CA-2502033-A1 (CA)
Inventor: JENKINS ROBERT L
IPC: E04D1/00
Filed: 2005-03-23
Abstract: A shingle is provided and its method of manufacture, in which granules are applied to an upper surface of a hardenable coating on a layer of shingle-making material, with granules of different pre-selected visual aesthetics provided in different tab areas, separated by mixtures of granules from adjacent tab areas forming intermediate areas, and in which the intermediate areas are removed to yield slots separating adjacent tabs, leaving visually sharp, precise starting and ending delineations for the tabs of a given aesthetic, that can be the same as or different than the aesthetic of an adjacent tab.
Patent CA-2505384-A1 (CA)
Title: Thermally crosslinkable materials and multi-layered devices therefrom
Inventor: D IORIO MARIE
IPC: H01L51/30
Filed: 2003-11-07
Abstract: The invention disclosed relates to cross-linkable composites of boronic acid or a boronic acid derivative such as a boronate, and an organic or organo-metallic moiety having a functionality such as hole transporting, electron transporting and light emitting, to cross-linked composites and to methods for making same. Multi-layer materials and optoelectronic devices including such cross-linked composites are also disclosed.
Patent CA-2505896-A1 (CA)
Title: A method for enhancing the stability of a water sensitive, reactive subterranean formation
Inventor: RAVI KRISHNA M
IPC: C09K8/50
Filed: 2003-10-24
Abstract: The current invention provides a method for enhancing the formation stability of water sensitive, reactive formations penetrated by a wellbore. The method of the current invention provides an accurate evaluation of the impact of cementing fluids on water sensitive, reactive formations and provides the ability to accurately formulate cementing fluids in order to enhance the stability of such formations. When necessary, the method of the current invention additionally provides for the application of an osmotic semi-permeable membrane to the face of the formation.
Patent CA-2508811-A1 (CA)
Inventor: KRISHNAMURTY DHILEEPKUMAR
IPC: C07D473/12
Filed: 2003-12-10
Abstract: Processes are disclosed for preparing the antiviral agent entecavir. A resin adsorption process for the isolation and purification of entecavir is also disclosed. Various intermediates useful in the preparation of entecavir are also disclosed.
Patent CA-2510711-A1 (CA)
Title: Novel aminobenzophenone compounds
Inventor: DANNACHER HEINZ WILHELM
IPC: C07D213/79
Filed: 2003-12-19
Abstract: The invention provides novel compounds according to formula (I) relates to compounds with the general formula (I), said compounds being useful, e.g. in the treatment of inflammatory diseases.
Patent CA-2513308-A1 (CA)
Title: Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods
Inventor: MICHL JOSEF
IPC: C07K14/47
Filed: 2004-01-16
Abstract: The present invention is directed to an antigen found on the surface of rat and human pancreatic cancer cells and provides antibodies of high specificity and selectivity to this antigen as well as hybridomas secreting the subject antibodies. Methods for both the diagnosis and treatment of pancreatic cancer are also provided. This tissue marker of pancreatic adenocarcinoma, an approximately 43.5 kD surface membrane protein designated PaCa-Agl, is completely unexpressed in normal pancreas but abundantly expressed in pancreatic carcinoma cells. Moreover, a soluble form of PaCa-Agl exists, having a molecular weight about 36 to about 38 kD, that is readily identified in sera and other body fluids of pancreatic cancer patients, using a subject antibody.
Patent CA-2513738-A1 (CA)
Title: Casr antagonist
Inventor: SOEJIMA YUKI
IPC: A61P19/08
Filed: 2004-04-23
Abstract: A compound of the following formula (1), its pharmaceutically acceptable salt or an optically active substance thereof. (in the formula, the symbols are as defined in the description). In particular, a compound having calcium sensitive receptor antagonism and a pharmaceutical composition comprising the compound, especially a calcium receptor antagonist and a therapeutic agent for osteoporosis.
Patent CA-2517544-A1 (CA)
Inventor: SCHIFFMAN RHETT M
IPC: A61P21/02
Filed: 2004-02-25
Abstract: A method for treating uterine disorders, including hyperplasic, hypertonic, cystic and/or neoplastic uterine gland tissue by local administration of a botulinum toxin to or to the vicinity of the afflicted uterine tissue.
Patent CA-2517837-A1 (CA)
Title: System and method for providing differentiated services
Inventor: ZHAO WEI
IPC: H04L47/41
Filed: 2004-03-05
Abstract: The present invention relates to a method and arrangements for updating the mapping of trade in the form of a set of service level aggregate flows (SLS1, SLSM) to a set of partial resources (B1, BN) for forwarding the traffic in a communications network (21). Each service level aggregate flow corresponds to a service level associated with a set of service requirements, Information regarding traffic characteristics of each service level aggregate flow and performance of the set of network resources are obtained. Based on this information, the mapping of the set of service level aggregate flows to the set of network resources is updated to achieve a more efficient utilization of the set of network resources, while fulfilling the set of service requirements. <IMAGE>
Patent CA-2518999-A1 (CA)
Title: Crystalline and amorphous solids of pantoprazole and processes for their preparation
Inventor: FINKELSTEIN NINA
IPC: C07D401/12
Filed: 2004-03-12
Abstract: The present invention relates to a polymorphic form (Form I) of pantoprazole and a processes of making same. Form I has a PXRD pattern with characteristic peaks at 6.6, 13.2, 13.7, 15.7, 23.1, and 23.4 .plusmn. 0.2 ~20 and a FTIR  spectrum with characteristic bands at 1385, 1264, 1244, 1180, and 1027 at cm-1. The process of making Form I includes crystallizing pantaoprazole or forming slurry from amorphous pantoprazole. The present invention also relates to another polymorphic form (Form II) of pantoprazole and a process of making the same. Form II has a PXRD pattern with characteristic peaks at 5.8, 7.5, 9.3, 15.0, 22.0, and 22.6 .plusmn. 0.2 ~20 and a FTIR spectrum with characteristic bands at 3195, 1196, and 1584 at cm-1. The process of making Form II includes forming a slurry from amorphous pantoprazole.
Patent CA-2520991-A1 (CA)
Title: Method of manufacturing an oriented film from alloyed thermoplastic polymers, apparatus for such manufacture and resulting products
Inventor: RASMUSSEN OLE-BENDT
IPC: B29C48/10
Filed: 2004-04-26
Abstract: A blend of two partly incompatible polymers is extruded to form a film under conditions such that the alloy in the blend comprises fibrils extending mainly in one direction, the width and thickness of each fibril having a mean lower than 5 ~m, the fibrils being formed of the polymer component having a higher melting point, and the fibrils being surrounded by a matrix of the second polymer, which has a lower coefficient of elasticity. The special morphology is achieved by providing grids (301, 302) in a grid chamber upstream of the exit orifice of the extrusion die, and by sequential hot stretching at a temperature at which the higher melting polymer is at least partly crystalline, and cold stretching, at which both polymers are substantially solid. The second, cold stretching step, is carried out under conditions to give an elongation at break at 20~C of at least 25%. The films are of particular value for forming crosslaminates having high shock resistance.  Preferably the polymer forming fibrils is polypropylene and the polymer forming the matrix is an ethylene polymer, preferably LLDPE.
Patent CA-2522700-A1 (CA)
Inventor: KUEMMERLE JARED
IPC: A61K38/17
Filed: 2004-04-19
Abstract: L'invention concerne une méthode de traitement, de prévention ou d'amélioration d'une maladie entraînant l'induction d'une cascade de caspase chez un animal, comprenant l'administration à un animal d'un composé qui se lie de manière spécifique à une ou plusieurs protéines inductrice de l'apoptose (AIPs). Lesdites AIPs comprennent des protéines inductrices de l'apoptose liées à un récepteur de la transferrine, des protéines inductrices de l'apoptose liées à la clathrine à chaîne lourde (CHCRAIPs), des protéines inductrices d'apoptose associées une protéine activant la GTPase contenant un motif de IQ (IQGAPRAIPs), et des protéines inductrices de l'apoptose associées à une protéine de choc à la chaleur (HSPRAIPs). L'invention concerne également des procédés de criblage utilisés pour découvrir des médicaments de composés associés à l'apoptose. En particulier, la méthodologie de criblage concerne l'utilisation d'AIPs en tant que cible pour découvrir des activateurs d'apoptose utilisés comme agents anticancéreux. Les procédés de criblage de l'invention peuvent comprendre des essais de liaison homogènes ou hétérogènes au moyen d'AIPs purifiés ou partiellement purifiés ; ou des essais cellulaires entiers au moyen de cellules à teneur modifiée d'une ou plusieurs AIP. L'invention concerne, de plus, l'utilisation d'acide gambogique ou des composés associés au GA, lesquels fixent les AIPs et peuvent être utilisés pour augmenter les anticorps utilisés pour la découverte de médicaments. En variante, le GA marqué est utilisé pour des essais de liaison compétitifs pour la découverte de médicaments. Lesdits essais fournissent un criblage du taux de bibliothèques chimiques pour des activateurs d'apoptose.
Patent CA-2526505-A1 (CA)
Title: Apparatus for facilitating urological procedures
Inventor: SINGH ERROL O
IPC: A61B1/07
Filed: 2004-05-21
Abstract: A flexible direct vision fiberoptical viewing or cable is provided for placement within a urinary catheter with its tip located at a distal end of the catheter such that the surfaces of the distal end of both the viewing cable and the catheter are aligned so as to fit together to form a composite smoothly curved surface to facilitate negotiating obstructions. The cable is maintained in this position such that the catheter with the surfaces that comprise the tip of the instrument are maintained in alignment. The urethra can be viewed therethrough during all or part of the insertion procedure for observing and identifying obstructions that may be present and thereafter the cable is withdrawn while allowing the catheter to remain in place within the urethra. The invention also includes a catheter that serves as a working sheath and an obturator. The invention facilitates endoscopic examination and can be used for performing surgical procedures through the sheath.
Patent CA-2533812-A1 (CA)
Title: Substituted cycloalkylidene compounds
Inventor: BRITTON JONATHAN E
IPC: C07C311/08
Filed: 2004-07-27
Abstract: The present invention relates to novel compounds with a variety of therapeutic uses, more particularly novel substituted cyclic alkylidene compounds that are particularly useful for selective estrogen receptor modulation. Formula (I) including salts, solvates, and pharmacologically functional derivatives thereof wherein R1is OH; each of R2 and R4 independently are selected from OH, alkyl, or halogen; each of p and q independently are selected from 0, 1, or 2;  R3 is -(Y)z-R6; z is 0 or 1; Y is -C=C- or CR6=CR1-; X is -(CH2)n- where n is 0, 1, 2, or 3, -C(R9)2-, -O-,or -S-.
Patent CA-2534037-A1 (CA)
Inventor: HARTMANN JENS
IPC: C09K8/36
Filed: 2004-07-20
Abstract: Disclosed is the use of ether carboxylic acids of general formula RO(CH2CH2O)x(CH2CHR1O)yCH2-COOX, wherein R represents a saturated or unsaturated, branched or unbranched alkyl radical or alkenyl radical comprising 6 to 22 C atoms, x represents a number between 1 and 20, and y represents 0 or a number between 1 and 20, provided that the sum of x and y is at least 1 and no more than 25, while R1 represents an alkyl radical comprising 1 to 4 C atoms and X represents a monovalent or polyvalent anion, in drilling fluids. The inventive ether carboxylic acids of said formula are preferably suitable as emulsifiers for invert drilling fluid systems.
Patent CA-2535460-A1 (CA)
Title: Nonlinear device detection
Inventor: CUNNINGHAM CHRISTOPHER C
IPC: H04M3/30
Filed: 2004-08-20
Abstract: Data is collected and interpreted in response to one or more transmitted signals to determine if an interfering device is present. If an interfering device is present, a message is generated and presented to a user indicating, for example, that the installation of a micro-filter is appropriate. The system can then determine if the micro-filter was installed properly and, for example, commence communication or, if the micro-filter(s) did not solve the problem, initiate communication with or contact a technician.
Patent CA-2541510-A1 (CA)
Title: Attachment means for hang glider simulator
Inventor: AUDET LEANDRE
IPC: B64F1/10
Filed: 2006-03-27
Abstract: An attachment means for hang glider simulator generally comprises a rod, pole or similar oblong means which is articulately attached at both ends to brackets able to rotate along three axes. One such bracket being attached to a vehicle while the other bracket is attached to a seating assembly attached to a hang glider. By moving the vehicle within a range of speed, a student can practice the controls on a real hang glider while maitaining a low safe altitude. Alternatively, a boat or other motorized water vehicle can perform a similar function by having a floater replace the wheel.
Patent CA-2542782-A1 (CA)
Inventor: KLATT ANDREAS
IPC: B65D5/50
Filed: 2004-10-22
Abstract: Medicine pack comprises blister units (1), each having a protective case (6), with a blister strip (4). The blister strip is fixedly connected to the protective case, which is capable of being unfolded or opened out. An outer package is provided for receiving the blister units. It is configured in a way that the pack content can be fixed in the inside of the outer package.
Patent CA-2544823-A1 (CA)
Inventor: HAMA HIROSHI
IPC: C23F11/14
Filed: 2003-11-10
Abstract: A rust preventive for magnesium and/or magnesium alloys which contains as an active ingredient at least one member selected from the group consisting of compounds represented by the formulae (1) and (2) and salts of these; and a process for producing a part made of magnesium or a magnesium alloy, which comprises using the rust preventive. (1) (2) (In the formulae, R1 represents hydrogen or C1-4 alkyl; R2 represents hydrogen, C1-4 alkyl, mercapto, or hydroxy; R3 represents hydrogen, C1-4 alkyl, or hydroxy; A represents -N= or -C(R4)=; and R4 represents hydrogen or amino.)